[Hypercalciuria under PAS-calcium medication as a pathogenic factor in urolithiasis. 1].
D000636:Aminosalicylic Acids / Q000009:adverse effects*; D002118:Calcium / Q000009:adverse effects* / Q000652:urine; D002128:Calcium Metabolism Disorders / Q000139:chemically induced / Q000150:complications*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006869:Hydronephrosis / Q000209:etiology; D008297:Male; D014388:Tuberculosis, Lymph Node / Q000188:drug therapy; D014391:Tuberculosis, Miliary / Q000188:drug therapy; D014394:Tuberculosis, Osteoarticular / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014545:Urinary Calculi / Q000139:chemically induced* / Q000150:complications; D014552:Urinary Tract Infections / Q000209:etiology; D014882:Water-Electrolyte Balance
D000636:Aminosalicylic Acids; D002118:Calcium
Hypercalciurie unter PAS-Calcium-Medikation als pathogenetischer Faktor der Urolithiasis. 1.